FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023103076> ?p ?o ?g. }

• W2023103076 endingPage "94" @default.
• W2023103076 startingPage "83" @default.
• W2023103076 abstract "Objectives: Macrophage migration inhibitory factor 1α (MIF), a cytokine with immunoregulatory functions has been suggested to be involved in atherosclerotic plaque development. However, little is known about MIF-inducing conditions in the atherosclerotic process and the association of MIF with plaque instability. Methods and results: Forty-two carotid endatherectomy samples from 36 patients and 4 aortic samples from young accident victims (as healthy controls) were analyzed for MIF staining. MIF expressing tissues in the atherosclerotic plaques are mainly mononuclear cells (MNCs), but also endothelial cells of intimal microvessels (MVECs). The magnitude and the intensity of their MIF expression was associated with the progression of plaques from early lesions (Stary I–III) to complicated plaque stages (Stary IV–VIII). In highly inflammatory and neovascularized regions of the plaques the colocalization of MIF expressing MNCs with CD40-L+ and angiotensin II (Ang II)-producing MNCs could be established. This finding supports the notion that CD40-L fusion protein and Ang II are able to induce MIF production in the monocytic cell line THP-1. Furthermore hypoxia (≤1% O2) as a further proinflammatory and especially proangiogenetic factor was able to stimulate MIF secretion by THP-1, human monocytes and HUVECs. Hyperglycemia and insulin remained without effect. Conclusion: MIF is expressed in advanced atherosclerotic lesions in close correlation with signs of instability, such as mononuclear cell inflammation and neointimal microvessel formation. Furthermore, the colocalization of MIF with Ang II-producing MNCs and CD40-L+ cells in these plaques and the finding that proathero- and -angiogenic mediators such as CD40-L, Ang II and hypoxia are able to stimulate MIF expression in vitro suggest an important role of MIF in the modulation of atherosclerotic plaque stability." @default.
• W2023103076 created "2016-06-24" @default.
• W2023103076 creator A5008306022 @default.
• W2023103076 creator A5016954466 @default.
• W2023103076 creator A5027871108 @default.
• W2023103076 creator A5048469868 @default.
• W2023103076 creator A5052177416 @default.
• W2023103076 creator A5055741201 @default.
• W2023103076 creator A5056517467 @default.
• W2023103076 creator A5071131587 @default.
• W2023103076 creator A5072725978 @default.
• W2023103076 creator A5088359235 @default.
• W2023103076 date "2005-01-01" @default.
• W2023103076 modified "2023-09-25" @default.
• W2023103076 title "The expression of macrophage migration inhibitory factor 1α (MIF 1α) in human atherosclerotic plaques is induced by different proatherogenic stimuli and associated with plaque instability" @default.
• W2023103076 cites W1577799117 @default.
• W2023103076 cites W1607784912 @default.
• W2023103076 cites W1957500099 @default.
• W2023103076 cites W1979244891 @default.
• W2023103076 cites W1980776191 @default.
• W2023103076 cites W1991138100 @default.
• W2023103076 cites W1993738876 @default.
• W2023103076 cites W1999819607 @default.
• W2023103076 cites W2001737701 @default.
• W2023103076 cites W2006691286 @default.
• W2023103076 cites W2008426709 @default.
• W2023103076 cites W2012103481 @default.
• W2023103076 cites W2012528026 @default.
• W2023103076 cites W2013839742 @default.
• W2023103076 cites W2017574292 @default.
• W2023103076 cites W2023837865 @default.
• W2023103076 cites W2026581928 @default.
• W2023103076 cites W2032439102 @default.
• W2023103076 cites W2040336985 @default.
• W2023103076 cites W2060000188 @default.
• W2023103076 cites W2068036925 @default.
• W2023103076 cites W2074253462 @default.
• W2023103076 cites W2075045160 @default.
• W2023103076 cites W2089398698 @default.
• W2023103076 cites W2090056328 @default.
• W2023103076 cites W2091050865 @default.
• W2023103076 cites W2092692976 @default.
• W2023103076 cites W2093078271 @default.
• W2023103076 cites W2107774819 @default.
• W2023103076 cites W2114631256 @default.
• W2023103076 cites W2122151701 @default.
• W2023103076 cites W2127569438 @default.
• W2023103076 cites W2134093518 @default.
• W2023103076 cites W2136133186 @default.
• W2023103076 cites W2140544322 @default.
• W2023103076 cites W2141991660 @default.
• W2023103076 cites W2146058212 @default.
• W2023103076 cites W2154360613 @default.
• W2023103076 cites W2202150720 @default.
• W2023103076 cites W2214780719 @default.
• W2023103076 cites W2295738042 @default.
• W2023103076 cites W2342153330 @default.
• W2023103076 cites W4250694871 @default.
• W2023103076 doi "https://doi.org/10.1016/j.atherosclerosis.2004.08.038" @default.
• W2023103076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15585204" @default.
• W2023103076 hasPublicationYear "2005" @default.
• W2023103076 type Work @default.
• W2023103076 sameAs 2023103076 @default.
• W2023103076 citedByCount "61" @default.
• W2023103076 countsByYear W20231030762012 @default.
• W2023103076 countsByYear W20231030762013 @default.
• W2023103076 countsByYear W20231030762014 @default.
• W2023103076 countsByYear W20231030762015 @default.
• W2023103076 countsByYear W20231030762016 @default.
• W2023103076 countsByYear W20231030762017 @default.
• W2023103076 countsByYear W20231030762018 @default.
• W2023103076 countsByYear W20231030762019 @default.
• W2023103076 countsByYear W20231030762022 @default.
• W2023103076 crossrefType "journal-article" @default.
• W2023103076 hasAuthorship W2023103076A5008306022 @default.
• W2023103076 hasAuthorship W2023103076A5016954466 @default.
• W2023103076 hasAuthorship W2023103076A5027871108 @default.
• W2023103076 hasAuthorship W2023103076A5048469868 @default.
• W2023103076 hasAuthorship W2023103076A5052177416 @default.
• W2023103076 hasAuthorship W2023103076A5055741201 @default.
• W2023103076 hasAuthorship W2023103076A5056517467 @default.
• W2023103076 hasAuthorship W2023103076A5071131587 @default.
• W2023103076 hasAuthorship W2023103076A5072725978 @default.
• W2023103076 hasAuthorship W2023103076A5088359235 @default.
• W2023103076 hasConcept C104177226 @default.
• W2023103076 hasConcept C126322002 @default.
• W2023103076 hasConcept C164027704 @default.
• W2023103076 hasConcept C202751555 @default.
• W2023103076 hasConcept C203014093 @default.
• W2023103076 hasConcept C2776914184 @default.
• W2023103076 hasConcept C2778690821 @default.
• W2023103076 hasConcept C2779244956 @default.
• W2023103076 hasConcept C40209533 @default.
• W2023103076 hasConcept C55493867 @default.
• W2023103076 hasConcept C71924100 @default.
• W2023103076 hasConcept C86803240 @default.
• W2023103076 hasConcept C95444343 @default.
• W2023103076 hasConceptScore W2023103076C104177226 @default.

• next